Tiago Fauth
Stock Analyst at Raymond James
(4.33)
# 1,316
Out of 5,076 analysts
311
Total ratings
45.1%
Success rate
9.6%
Average return
Main Sectors:
Stocks Rated by Tiago Fauth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BNTC Benitec Biopharma | Initiated Coverage: Buy | $14 | $8.65 | +61.85% | 1 | Oct 23, 2026 | |
| INSM Insmed | Reiterated: Buy | $185 → $173 | $93.39 | +85.24% | 24 | Oct 20, 2026 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $84 → $79 | $42.93 | +84.02% | 4 | Oct 20, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $6 → $5 | $0.6482 | +671.37% | 2 | Oct 20, 2026 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $95 → $106 | $60.59 | +74.95% | 23 | Oct 20, 2026 | |
| RAPP Rapport Therapeutics | Reiterated: Buy | $86 | $25.93 | +231.66% | 4 | Oct 20, 2026 | |
| TNXP Tonix Pharmaceuticals Holding | Reiterated: Buy | $27 → $26 | $5.17 | +402.90% | 3 | Oct 20, 2026 | |
| UTHR United Therapeutics | Reiterated: Buy | $700 → $717 | $587.50 | +22.04% | 27 | Oct 20, 2026 | |
| IRLA IRulya Therapeutics | Initiated Coverage: Buy | $72 | $33.08 | +117.65% | 1 | Oct 9, 2026 | |
| AVLN Avalyn Pharma | Initiated Coverage: Buy | $60 | $26.04 | +130.41% | 1 | Oct 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $20.61 | +123.19% | 1 | Sep 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $945 | $252.96 | +273.58% | 3 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $1.85 | +224.32% | 1 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $7.97 | +477.16% | 1 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $76 → $98 | $68.56 | +42.94% | 18 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $227 → $239 | $214.00 | +11.68% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 → $20 | $11.28 | +77.30% | 11 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $7 | $3.19 | +119.44% | 6 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $18 | $3.18 | n/a | 11 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $31 | $42.65 | n/a | 6 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $101 | $20.07 | n/a | 7 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $333 → $395 | $224.03 | n/a | 13 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $88 → $65 | $15.65 | n/a | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $4.22 | n/a | 4 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $74.51 | n/a | 5 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $3 | $0.8636 | n/a | 9 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $10.59 | n/a | 1 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $35 → $70 | $14.59 | n/a | 6 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $89 | $243.37 | n/a | 22 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 | $55.95 | n/a | 8 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $51 | $22.37 | n/a | 3 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $45.15 | n/a | 4 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 → $26 | $9.61 | n/a | 6 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $28 | $11.82 | n/a | 9 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 | $1.56 | n/a | 6 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 → $34 | $1.17 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $21.09 | n/a | 3 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $13 | $4.66 | n/a | 1 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $33 → $13 | $2.40 | n/a | 4 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $14 | $1.68 | n/a | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $14 | $9.18 | n/a | 3 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $340 → $319 | $873.71 | n/a | 9 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $12 → $7 | $28.41 | n/a | 7 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $265 → $259 | $439.26 | n/a | 2 | Apr 28, 2021 |
Benitec Biopharma
Oct 23, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $8.65
Upside: +61.85%
Insmed
Oct 20, 2026
Reiterated: Buy
Price Target: $185 → $173
Current: $93.39
Upside: +85.24%
Ionis Pharmaceuticals
Oct 20, 2026
Reiterated: Buy
Price Target: $84 → $79
Current: $42.93
Upside: +84.02%
Milestone Pharmaceuticals
Oct 20, 2026
Reiterated: Buy
Price Target: $6 → $5
Current: $0.6482
Upside: +671.37%
PTC Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $95 → $106
Current: $60.59
Upside: +74.95%
Rapport Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $86
Current: $25.93
Upside: +231.66%
Tonix Pharmaceuticals Holding
Oct 20, 2026
Reiterated: Buy
Price Target: $27 → $26
Current: $5.17
Upside: +402.90%
United Therapeutics
Oct 20, 2026
Reiterated: Buy
Price Target: $700 → $717
Current: $587.50
Upside: +22.04%
IRulya Therapeutics
Oct 9, 2026
Initiated Coverage: Buy
Price Target: $72
Current: $33.08
Upside: +117.65%
Avalyn Pharma
Oct 2, 2026
Initiated Coverage: Buy
Price Target: $60
Current: $26.04
Upside: +130.41%
Sep 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $20.61
Upside: +123.19%
Aug 17, 2026
Reiterated: Buy
Price Target: $945
Current: $252.96
Upside: +273.58%
Aug 13, 2026
Initiated Coverage: Buy
Price Target: $6
Current: $1.85
Upside: +224.32%
Jun 25, 2026
Initiated Coverage: Buy
Price Target: $46
Current: $7.97
Upside: +477.16%
Jun 17, 2026
Reiterated: Buy
Price Target: $76 → $98
Current: $68.56
Upside: +42.94%
May 6, 2026
Reiterated: Buy
Price Target: $227 → $239
Current: $214.00
Upside: +11.68%
Mar 5, 2026
Reiterated: Buy
Price Target: $26 → $20
Current: $11.28
Upside: +77.30%
Feb 27, 2026
Reiterated: Buy
Price Target: $10 → $7
Current: $3.19
Upside: +119.44%
Sep 4, 2025
Reiterated: Buy
Price Target: $21 → $18
Current: $3.18
Upside: n/a
Aug 13, 2025
Reiterated: Buy
Price Target: $25 → $31
Current: $42.65
Upside: n/a
Aug 7, 2025
Reiterated: Buy
Price Target: $101
Current: $20.07
Upside: n/a
Aug 1, 2025
Reiterated: Hold
Price Target: $333 → $395
Current: $224.03
Upside: n/a
Jul 9, 2025
Reiterated: Buy
Price Target: $88 → $65
Current: $15.65
Upside: n/a
May 28, 2025
Reiterated: Buy
Price Target: $8 → $7
Current: $4.22
Upside: n/a
May 8, 2025
Reiterated: Buy
Price Target: $91
Current: $74.51
Upside: n/a
Mar 4, 2025
Reiterated: Hold
Price Target: $4 → $3
Current: $0.8636
Upside: n/a
Aug 22, 2024
Initiated Coverage: Hold
Price Target: $16
Current: $10.59
Upside: n/a
Jun 17, 2024
Downgraded: Hold
Price Target: $35 → $70
Current: $14.59
Upside: n/a
Jun 13, 2023
Initiated Coverage: Hold
Price Target: $89
Current: $243.37
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $120
Current: $55.95
Upside: n/a
Jun 13, 2023
Initiated Coverage: Buy
Price Target: $51
Current: $22.37
Upside: n/a
May 16, 2023
Reiterated: Buy
Price Target: $4
Current: $45.15
Upside: n/a
May 11, 2023
Reiterated: Buy
Price Target: $29 → $26
Current: $9.61
Upside: n/a
May 5, 2023
Reiterated: Buy
Price Target: $34 → $28
Current: $11.82
Upside: n/a
Apr 5, 2023
Reiterated: Sell
Price Target: $2
Current: $1.56
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $38 → $34
Current: $1.17
Upside: n/a
Mar 10, 2023
Reiterated: Buy
Price Target: $7 → $6
Current: $21.09
Upside: n/a
Dec 16, 2022
Initiated Coverage: Buy
Price Target: $13
Current: $4.66
Upside: n/a
Nov 17, 2022
Downgraded: Hold
Price Target: $33 → $13
Current: $2.40
Upside: n/a
Aug 15, 2022
Reiterated: Buy
Price Target: $19 → $14
Current: $1.68
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $28 → $14
Current: $9.18
Upside: n/a
Mar 3, 2022
Reiterated: Hold
Price Target: $340 → $319
Current: $873.71
Upside: n/a
Aug 2, 2021
Downgraded: Sell
Price Target: $12 → $7
Current: $28.41
Upside: n/a
Apr 28, 2021
Reiterated: Buy
Price Target: $265 → $259
Current: $439.26
Upside: n/a